Drug Approvals KG version 0.3.5

<b>Description</b>: The Drug Approvals KG, created and maintained by the Multiomics Provider, provides assertions about regulatory approvals of drug interventions for treating diseases, and observations of off-label use of drug interventions. These assertions and observations are derived through integration of content from DailyMed and the FDA's adverse-event reporting system (FAERS).<b>Example</b>: The Drug Approvals KG shows that leuprolide treats prostate cancer. This assertion is supported by 11 approved New Drug Applications, including NDA019732, and 7 product labels, including LEUPROLIDE ACETATE DEPOT- leuprolide acetate kit. The Drug Approvals KG also shows that risperidone is applied to treat ADHD, off-label. This observation is supported by tens of thousands of case reports in FAERS.The graph currently uses biolink:treats and biolink:applied_to_treat as predicates. Node categories include biolink:SmallMolecule, biolink:ChemicalEntity, and biolink:MolecularMixture for the interventions, and biolink:Disease and biolink:PhenotypicFeature for the conditions.